These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12534090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New treatment approach. Patients with neurodermatitis need less cortisone].
    MMW Fortschr Med; 2003 Feb 06; 145(6):59. PubMed ID: 12619368
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ].
    MMW Fortschr Med; 2003 Jul 24; 145(29-30):62. PubMed ID: 12958787
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D.
    Am J Ther; 2009 Jul 24; 16(3):264-73. PubMed ID: 19262357
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT, Thaçi D, Luger T.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep 24; 146(1):22-9. PubMed ID: 19631446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR, Martin JA, Finlay AY.
    Am J Clin Dermatol; 2009 Sep 24; 10(4):229-37. PubMed ID: 19489656
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus and tacrolimus: the US FDA public health advisory.
    Maddin S.
    Skin Therapy Lett; 2005 May 24; 10(4):1-3. PubMed ID: 15986080
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of steroid-resistant nodular scabies with topical pimecrolimus.
    Almeida HL.
    J Am Acad Dermatol; 2005 Aug 24; 53(2):357-8. PubMed ID: 16021143
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Topical pimecrolimus and tacrolimus and the risk of cancer].
    Sánchez-Pérez J.
    Actas Dermosifiliogr; 2007 Jun 24; 98(5):312-7. PubMed ID: 17555673
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential new indications of topical calcineurin inhibitors.
    Luger T, Paul C.
    Dermatology; 2007 Jun 24; 215 Suppl 1():45-54. PubMed ID: 18174692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.